| Predicting response to immunotherapy by evaluating tumors, lymphoid cell-rich organs, and immune-related adverse events using FDG-PET/CT T Nobashi, L Baratto, SA Reddy, S Srinivas, A Toriihara, N Hatami, ... Clinical nuclear medicine 44 (4), e272-e279, 2019 | 89 | 2019 |
| Evaluation of integrin αvβ6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis RH Kimura, L Wang, B Shen, L Huo, W Tummers, FV Filipp, HH Guo, ... Nature communications 10 (1), 4673, 2019 | 87 | 2019 |
| Prostate cancer theranostics targeting gastrin-releasing peptide receptors L Baratto, H Jadvar, A Iagaru Molecular imaging and biology 20, 501-509, 2018 | 80 | 2018 |
| End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making C Melani, R Advani, M Roschewski, KM Walters, CC Chen, L Baratto, ... Haematologica 103 (8), 1337, 2018 | 76 | 2018 |
| 18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT L Baratto, SY Park, N Hatami, G Davidzon, S Srinivas, SS Gambhir, ... PloS one 12 (6), e0178936, 2017 | 58 | 2017 |
| Initial experience with a SiPM-based PET/CT scanner: influence of acquisition time on image quality I Sonni, L Baratto, S Park, N Hatami, S Srinivas, G Davidzon, SS Gambhir, ... EJNMMI physics 5, 1-12, 2018 | 55 | 2018 |
| Artificial intelligence enables whole-body positron emission tomography scans with minimal radiation exposure YR Wang, L Baratto, KE Hawk, AJ Theruvath, A Pribnow, AS Thakor, ... European journal of nuclear medicine and molecular imaging 48, 2771-2781, 2021 | 54 | 2021 |
| Imaging the distribution of gastrin-releasing peptide receptors in cancer L Baratto, H Duan, H Mäcke, A Iagaru Journal of Nuclear Medicine 61 (6), 792-798, 2020 | 53 | 2020 |
| PSMA-and GRPR-targeted PET: results from 50 patients with biochemically recurrent prostate cancer L Baratto, H Song, H Duan, N Hatami, HP Bagshaw, M Buyyounouski, ... Journal of Nuclear Medicine 62 (11), 1545-1549, 2021 | 52 | 2021 |
| Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine … A Toriihara, L Baratto, T Nobashi, S Park, N Hatami, G Davidzon, PL Kunz, ... European journal of nuclear medicine and molecular imaging 46, 2244-2251, 2019 | 49 | 2019 |
| Comparison of 3 interpretation criteria for 68Ga-PSMA11 PET based on inter-and intrareader agreement A Toriihara, T Nobashi, L Baratto, H Duan, F Moradi, S Park, N Hatami, ... Journal of Nuclear Medicine 61 (4), 533-539, 2020 | 46 | 2020 |
| Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements L Baratto, H Duan, R Laudicella, A Toriihara, N Hatami, V Ferri, A Iagaru European Journal of Nuclear Medicine and Molecular Imaging 47, 115-122, 2020 | 35 | 2020 |
| 18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition L Baratto, SY Park, N Hatami, P Gulaka, S Vasanawala, TK Yohannan, ... EJNMMI research 8, 1-7, 2018 | 34 | 2018 |
| Clinical Evaluation of 68Ga-PSMA-II and 68Ga-RM2 PET Images Reconstructed With an Improved Scatter Correction Algorithm KA Wangerin, L Baratto, MM Khalighi, TA Hope, PK Gulaka, TW Deller, ... American Journal of Roentgenology 211 (3), 655-660, 2018 | 23 | 2018 |
| The effect of various β values on image quality and semiquantitative measurements in 68Ga-RM2 and 68Ga-PSMA-11 PET/MRI images reconstructed with a block sequential regularized … L Baratto, H Duan, V Ferri, M Khalighi, A Iagaru Clinical Nuclear Medicine 45 (7), 506-513, 2020 | 22 | 2020 |
| Comparison between different PET and CT-based imaging interpretation criteria at interim imaging in patients with diffuse large B-cell lymphoma L Baratto, GA Davidzon, M Moghbel, N Hatami, A Iagaru, ES Mittra Clinical Nuclear Medicine 43 (1), 1-8, 2018 | 21 | 2018 |
| Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas R Laudicella, N Quartuccio, G Argiroffi, P Alongi, L Baratto, E Califaretti, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 3925-3939, 2021 | 18 | 2021 |
| Correlation of 68Ga-RM2 PET with postsurgery histopathology findings in patients with newly diagnosed intermediate-or high-risk prostate cancer H Duan, L Baratto, RE Fan, SJC Soerensen, T Liang, BI Chung, ... Journal of Nuclear Medicine 63 (12), 1829-1835, 2022 | 17 | 2022 |
| PET/MRI improves management of children with cancer L Baratto, KE Hawk, J Qi, S Gatidis, L Kiru, HE Daldrup-Link Journal of Nuclear Medicine 62 (10), 1334-1340, 2021 | 16 | 2021 |
| Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[18F] F and [18F]FDG: a Focus on Skeletal Lesions I Sonni, R Minamimoto, L Baratto, SS Gambhir, AM Loening, ... Molecular Imaging and Biology 22, 397-406, 2020 | 16 | 2020 |
Andrei IagaruStanford UniversityПідтверджена електронна адреса в stanford.edu
